Cannabis Bioscience International Holdings, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OID
Cannabis Bioscience International Holdings sold 250 million shares to a director, John Jones, for $75,000, with a repurchase agreement if the share value doesn't reach a certain level by the end of 2025.
OID
Cannabis Bioscience International Holdings has appointed Charles Tamburello to its board of directors and established an executive committee with full board authority, subject to certain limitations.
OID
Cannabis Bioscience International Holdings has entered into a master research agreement with Alpha Research Institute and appointed John Jones as a director and treasurer, while also adjusting interest rates on a promissory note.
OID
8-K: Cannabis Bioscience International Secures $66,000 Bridge Financing Through Note Purchase Agreement
Cannabis Bioscience International Holdings, Inc. has entered into a Securities Purchase Agreement to issue a $66,000 bridge note to 1800 Diagonal Lending LLC.